This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Thrombogenics Nv. Active years: 2014-2015.
Company Filing History:
Years Active: 2014-2015
Title: Ingeborg Stalmans: Innovator in Trabeculectomy Surgery
Introduction
Ingeborg Stalmans is a notable inventor based in Knokke, Belgium. She has made significant contributions to the field of ophthalmology, particularly in improving trabeculectomy surgery outcomes. With a total of two patents to her name, her work focuses on enhancing surgical techniques and patient recovery.
Latest Patents
Stalmans' latest patents include "Improving trabeculectomy outcome by administering an anti-placental growth factor antibody." This invention aims to extend the lifetime of the sclera-corneal drainage channel created during trabeculectomy surgery. The improvement is achieved through the post-surgical administration of an anti-PlGF antibody or its fragments. Another significant patent is "Method for treating filtration failure after trabeculectomy surgery." This invention also seeks to enhance the outcomes of trabeculectomy by administering plasmin or its active derivatives in the form of topical eye drops or through anterior chamber injections.
Career Highlights
Ingeborg Stalmans is associated with Thrombogenics NV, where she continues to innovate in the field of eye surgery. Her work has been instrumental in advancing techniques that improve patient outcomes and reduce complications associated with trabeculectomy.
Collaborations
Stalmans has collaborated with notable colleagues, including Bart Jonckx and Tine Van Bergen. These partnerships have contributed to her research and development efforts in ophthalmology.
Conclusion
Ingeborg Stalmans is a pioneering inventor whose work in trabeculectomy surgery has the potential to significantly improve patient care. Her innovative patents reflect her commitment to advancing medical science and enhancing surgical outcomes.